{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:17:20Z","timestamp":1790061440343,"version":"4.0.1"},"reference-count":32,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"name":"JDRF"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Diabttes Association"},{"name":"Heart and Stroke Foundation of Canada"},{"name":"SickKids Labatt Family Heart Center Innovation Fund"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The relationship between plasma uric acid (PUA) and renal and cardiovascular parameters in adolescents with type 1 diabetes (T1D) is not well understood. Our aims in this exploratory analysis were to study the association between PUA and estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (ACR), blood pressure, endothelial function, and arterial stiffness in T1D adolescents. These associations were also studied in healthy control (HC) subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We studied 188 T1D subjects recruited to the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) and 65 HC subjects. Baseline PUA, eGFRcystatin C, ACR, blood pressure, flow-mediated dilation (FMD), and carotid-femoral pulse wave velocity (PWV) were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>PUA was lower in T1D vs. HC subjects (242 \u00b1 55 vs. 306 \u00b1 74 \u03bcmol\/L, respectively; P &amp;lt; 0.0001). Higher PUA was inversely associated with eGFR in T1D subjects (r = \u22120.48, P &amp;lt; 0.0001) even after correction for baseline clinical demographic characteristics. PUA was not associated with ACR in T1D after adjustment for potential confounders such as eGFR. For cardiovascular parameters, PUA levels did not associate with systolic blood pressure, FMD, or PWV in T1D or HC subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Even within the physiological range, PUA levels were significantly lower in T1D adolescent patients compared with HC subjects. There was an inverse relationship between PUA and eGFR in T1D, likely reflecting an increase in clearance. There were no associations observed with ACR, blood pressure, arterial stiffness, or endothelial function. Thus, in contrast with adults, PUA may not yet be associated with cardiorenal abnormalities in adolescents with T1D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc15-2345","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T04:03:54Z","timestamp":1455941034000},"page":"611-616","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":21,"title":["Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 Diabetes"],"prefix":"10.2337","volume":"39","author":[{"given":"Yuliya","family":"Lytvyn","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada"},{"name":"Division of Nephrology, Department of Medicine, The University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid H.","family":"Mahmud","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Paediatrics and JDRF Canadian Clinical Trial Network SickKids Multicenter Clinical Trial Center, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Daneman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Paediatrics and JDRF Canadian Clinical Trial Network SickKids Multicenter Clinical Trial Center, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Deda","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Paediatrics and JDRF Canadian Clinical Trial Network SickKids Multicenter Clinical Trial Center, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Dunger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cambridge, Cambridge, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Deanfield","sequence":"additional","affiliation":[{"name":"University College Hospital, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Neil","family":"Dalton","sequence":"additional","affiliation":[{"name":"WellChild Laboratory, Evelina London Children's Hospital, St Thomas' Hospital, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesmino","family":"Elia","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Paediatrics and JDRF Canadian Clinical Trial Network SickKids Multicenter Clinical Trial Center, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Har","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Slorach","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hui","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Moineddin","sequence":"additional","affiliation":[{"name":"Department of Family & Community Medicine, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather N.","family":"Reich","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Scholey","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mertens","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sochett","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Paediatrics and JDRF Canadian Clinical Trial Network SickKids Multicenter Clinical Trial Center, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"2022031220230791000_B1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcjd.2014.10.013","article-title":"Uric acid as a biomarker and a therapeutic target in diabetes","volume":"39","author":"Lytvyn","year":"2015","journal-title":"Can J Diabetes"},{"key":"2022031220230791000_B2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11892-013-0381-0","article-title":"Uric acid lowering to prevent kidney function loss in diabetes: the Preventing Early Renal Function Loss (PERL) allopurinol study","volume":"13","author":"Maahs","year":"2013","journal-title":"Curr Diab Rep"},{"key":"2022031220230791000_B3","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","article-title":"Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents","volume":"115","author":"Ford","year":"2007","journal-title":"Circulation"},{"key":"2022031220230791000_B4"},{"key":"2022031220230791000_B5"},{"key":"2022031220230791000_B6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/pedi.12199","article-title":"Association of serum uric acid levels to inflammation biomarkers and endothelial dysfunction in obese prepubertal children","volume":"16","author":"Valle","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"2022031220230791000_B7","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1152\/ajprenal.00555.2014","article-title":"Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus","volume":"308","author":"Lytvyn","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031220230791000_B8","article-title":"Plasma uric acid effects on glomerular haemodynamic profile of patients with uncomplicated type\u00a01 diabetes mellitus","author":"Lytvyn","journal-title":"Diabet Med"},{"key":"2022031220230791000_B9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2431-9-79","article-title":"Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)","volume":"9","author":"Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial Research Group","year":"2009","journal-title":"BMC Pediatr"},{"key":"2022031220230791000_B10"},{"key":"2022031220230791000_B11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/diacare.22.3.495","article-title":"Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study","volume":"22","author":"Schultz","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031220230791000_B12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365510410003723","article-title":"Calculation of glomerular filtration rate expressed in mL\/min from plasma cystatin C values in mg\/L","volume":"64","author":"Larsson","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"2022031220230791000_B13","doi-asserted-by":"crossref","first-page":"e111131","DOI":"10.1371\/journal.pone.0111131","article-title":"The urinary cytokine\/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes","volume":"9","author":"Har","year":"2014","journal-title":"PLoS One"},{"key":"2022031220230791000_B14","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00125-013-2857-5","article-title":"The effect of renal hyperfiltration on urinary inflammatory cytokines\/chemokines in patients with uncomplicated type 1 diabetes mellitus","volume":"56","author":"Har","year":"2013","journal-title":"Diabetologia"},{"key":"2022031220230791000_B15"},{"key":"2022031220230791000_B16","doi-asserted-by":"crossref","first-page":"R710","DOI":"10.1152\/ajpregu.00286.2012","article-title":"Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus","volume":"303","author":"Cherney","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022031220230791000_B17","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc09-2340","article-title":"Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes","volume":"33","author":"Cherney","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031220230791000_B18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/diacare.12.10.686","article-title":"Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects","volume":"12","author":"Kostraba","year":"1989","journal-title":"Diabetes Care"},{"key":"2022031220230791000_B19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2337\/diab.45.1.51","article-title":"Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM","volume":"45","author":"Lawson","year":"1996","journal-title":"Diabetes"},{"key":"2022031220230791000_B20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00592-014-0611-1","article-title":"Serum uric acid predicts vascular complications in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study","volume":"51","author":"Bjornstad","year":"2014","journal-title":"Acta Diabetol"},{"key":"2022031220230791000_B21","doi-asserted-by":"crossref","first-page":"f4262","DOI":"10.1136\/bmj.f4262","article-title":"Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts","volume":"347","author":"Palmer","year":"2013","journal-title":"BMJ"},{"key":"2022031220230791000_B22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jdiacomp.2013.12.007","article-title":"Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes","volume":"28","author":"Bjornstad","year":"2014","journal-title":"J Diabetes Complications"},{"key":"2022031220230791000_B23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdd.1909","article-title":"SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria","volume":"35","author":"Chino","year":"2014","journal-title":"Biopharm Drug Dispos"},{"key":"2022031220230791000_B24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-0227","article-title":"High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up","volume":"33","author":"Ficociello","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031220230791000_B25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/dc13-0985","article-title":"Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria","volume":"37","author":"Krolewski","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031220230791000_B26","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031220230791000_B27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MNH.0b013e3283293db1","article-title":"Early nephropathy in type 1 diabetes: the importance of early renal function decline","volume":"18","author":"Perkins","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2022031220230791000_B28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/000992289503400103","article-title":"Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus","volume":"34","author":"Quattrin","year":"1995","journal-title":"Clin Pediatr (Phila)"},{"key":"2022031220230791000_B29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/ndt\/gfp740","article-title":"Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study","volume":"25","author":"Jalal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2022031220230791000_B30","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/db09-0014","article-title":"Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study","volume":"58","author":"Hovind","year":"2009","journal-title":"Diabetes"},{"key":"2022031220230791000_B31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.183244","article-title":"Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006","volume":"59","author":"Loeffler","year":"2012","journal-title":"Hypertension"},{"key":"2022031220230791000_B32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jch.12305","article-title":"Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes","volume":"16","author":"Bjornstad","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc15-2345","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/4\/611\/626172\/dc152345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/4\/611\/626172\/dc152345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:20:34Z","timestamp":1647123634000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/4\/611\/28992\/Association-Between-Plasma-Uric-Acid-Levels-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,2,19]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc15-2345","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]}}}